secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tarsus Pharmaceuticals, Inc. (TARS)
CIK:        0001819790
Form:       8-K
Filed at:   2025-01-13T23:59:59+00:00
Accession:  0001193125-25-005030
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tarsus Pharmaceuticals posts corporate presentation on investor website
-----------------------------------------------------------------------

- Published January 13, 2025, on the Investor & News section of Tarsus website.
- Presentation titled 'The Future of Eye Care Begins Here' filed as Exhibit 99.1.
- No specific financial guidance, product updates, or material events disclosed.
- Tarsus (NASDAQ: TARS) is focused on eye care, with XDEMVY as a key product.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819790/000119312525005030/0001193125-25-005030-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819790/000119312525005030/d892013d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-005030

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer